AVEO Pharmaceuticals (AVEO) Tops Q4 EPS by 3c

AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q4 EPS of ($0.58), $0.03 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $4.3 million.

For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance